Over 1850 Total Lots Up For Auction at Six Locations - MA 04/30, NJ Cleansweep 05/02, TX 05/03, TX 05/06, NJ 05/08, WA 05/09

Carestream Molecular Imaging Announces New KODAK X-SIGHT Dyes for In Vivo Imaging Applications

by Barbara Kram, Editor | September 10, 2007
PROVIDENCE, RI (Joint Molecular Imaging Conference) - Carestream Molecular Imaging, a division of Carestream Health, Inc., added to its KODAK X-SIGHT Imaging Agent family of products by introducing new large Stokes shift dyes for fluorescent in vivo imaging applications. KODAK X-SIGHT Large Stokes Shift Dyes are novel, reactive dyes that leverage 50 years of KODAK Dye chemistry expertise. They enable researchers and scientists to maximize the fluorescent signal while minimizing auto-fluorescence issues during in vivo imaging.

KODAK X-SIGHT Imaging Agents along with KODAK In-Vivo Imaging Systems and other products are currently being shown at the Joint AMI/SMI Molecular Imaging Conference in Providence, RI.

"Our new KODAK X-SIGHT Large Stokes Shift Dyes, characterized by near infrared emission and a large Stokes shift, enable researchers to achieve a higher sensitivity of fluorescent detection deeper into tissue," said Shahram Hejazi, PhD, President of Carestream Molecular Imaging. "With superior performance when compared to other commercially available products, these new dyes validate our outstanding dye chemistry expertise and leadership in fluorescent imaging."

Large Stokes Shift: Less Background, More Signal
"Stokes shift" refers to the separation of absorption and emission maxima. Having a significantly larger Stokes shift-greater than 80 nanometers in the case of KODAK X-SIGHT Dyes-helps researchers eliminate much of the background that typically obstructs the fluorescent signal while allowing researchers to excite and emit the dyes at their maxima, thus resulting in far greater signal to noise. Most commercially available dyes typically have a Stokes shift between 20-30 nanometers.

In an organism, the KODAK X-SIGHT Dyes can illuminate a region of interest when excited by the appropriate wavelength of fluorescent light, thus allowing the researcher to visualize their target. While the KODAK X-SIGHT Imaging Agents have been optimized for KODAK Image Station and In-Vivo Systems, they are also compatible with other commercially available digital imaging systems.

Availability
KODAK X-SIGHT Dyes will be available this fall for preclinical use. For more information on KODAK X-SIGHT Imaging Agents, please go to http://mistore.carestreamhealth.com/